Litcius/Paper detail

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

Philipp Koehler, Matteo Bassetti, Arunaloke Chakrabarti, Sharon C.‐A. Chen, Arnaldo Lopes Colombo, Martin Hoenigl, Н Н Климко, Cornelia Lass‐Flörl, Rita Oladele, Donald C. Vinh, Liping Zhu, Boris Böll, Roger J. M. Brüggemann, Jean‐Pierre Gangneux, John R. Perfect, Thomas F. Patterson, Thorsten Persigehl, Jacques F. Meis, Luis Ostrosky‐Zeichner, P. Lewis White, Paul E. Verweij, Oliver A. Cornely

2020The Lancet Infectious Diseases953 citationsDOIOpen Access PDF

Topics & Concepts

VoriconazoleIntensive care medicinePulmonary aspergillosisAspergillosisMedicineAspergillus fumigatusImmunologyAntifungalDermatologyAntifungal resistance and susceptibilityAntimicrobial Resistance in StaphylococcusBacterial biofilms and quorum sensing
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance | Litcius